The 3 Small CRISPR Biotechs That Could Cure 10,000 Diseases Post author:Sam Post published:February 4, 2018 Post category:BioPharma A look at three small biotech companies that appear to be leading the CRISPR race. Source: BioSpace You Might Also Like Top 20 Life Science Startups to Watch in 2018 January 1, 2018 VANC Pharmaceuticals Receives Updated Health Canada Approval For Hema-Fer With New Indication For Use In Pregnancy August 24, 2017 Celgene ReleaseData Presented At 2017 Further Evaluate Role Of ABRAXANE For Patients With Historically Challenging Cancers September 7, 2017
VANC Pharmaceuticals Receives Updated Health Canada Approval For Hema-Fer With New Indication For Use In Pregnancy August 24, 2017
Celgene ReleaseData Presented At 2017 Further Evaluate Role Of ABRAXANE For Patients With Historically Challenging Cancers September 7, 2017
